Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
590
2
78

Year Published

2017
2017
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 886 publications
(675 citation statements)
references
References 1,017 publications
5
590
2
78
Order By: Relevance
“…Dose adjustments are suggested in patients with eGFR between 50 and 30 mL/min for rivaroxaban and edoxaban as well as in patients with creatinine >1.5 mg/dL plus age ≥80 years or weight ≤60 kg for apixaban [19]. These indications are derived from post hoc analysis of the large trials comparing warfarin with the new drugs (see below).…”
Section: Novel Oral Anticoagulants and Ckdmentioning
confidence: 99%
See 1 more Smart Citation
“…Dose adjustments are suggested in patients with eGFR between 50 and 30 mL/min for rivaroxaban and edoxaban as well as in patients with creatinine >1.5 mg/dL plus age ≥80 years or weight ≤60 kg for apixaban [19]. These indications are derived from post hoc analysis of the large trials comparing warfarin with the new drugs (see below).…”
Section: Novel Oral Anticoagulants and Ckdmentioning
confidence: 99%
“…European Society of Cardiology (ESC), American Heart Association (AHA) and American College of Cardiology (ACC) Guidelines recommend using the CHA2DS2-VASc Score to assess the risk of stroke in patients with AF. ESC Guidelines [19] recommend patients with risk factor(s) ≥1 to receive effective stroke prevention therapy. Antithrombotic therapy is not recommended in patients with AF (irrespective of gender) who are <65 years old and with lone AF, as they have very low absolute event rates.…”
Section: Percutaneous Laa Occlusionmentioning
confidence: 99%
“…n Adapted from Ehrlich et al, 2013 5 In 2016, a core group formulated and published the most recent European Society of Cardiology (ESC) guidelines for the management of AF. 7 These guidelines were the focus of their own session, starting with an overview and then a closer look at some of the significantly modified recommendations pertaining to the treatment of AF.…”
Section: Focal Triggersmentioning
confidence: 99%
“…The most common serious complications of AF ablation are cardiac tamponade and vascular complications, 7 and many other issues that cannot be prevented by keeping patients in overnight. "It's not suitable for everyone, but day-case AF ablation is feasible for some patients," said Prof Schilling.…”
Section: Protagonistmentioning
confidence: 99%
“…Favorable results were reported for a treatment strategy with dual therapy (DT) using single antiplatelet therapy plus vitamin K antagonists (VKAs) after PCI [710]. Novel oral anticoagulants (NOACs) are suitable alternatives to VKAs for stroke prevention in non-valvular AF and their use in clinical practice is increasing rapidly [11], also driven by guideline recommendation as first-line preference [12]. DT using NOACs and P2Y 12 inhibitors may replace TT in AF patients with PCI, but so far, many questions are still open regarding this new antithrombotic strategy.…”
Section: Introductionmentioning
confidence: 99%